Navigation Links
IPC The Hospitalist Company, Inc. to Present at the 2008 UBS Global Healthcare Services Conference
Date:2/4/2008

NORTH HOLLYWOOD, Calif., Feb. 4 /PRNewswire-FirstCall/ -- IPC The Hospitalist Company, Inc. (Nasdaq: IPCM), a leading provider of hospitalist services, announced today that Adam D. Singer, Chief Executive Officer, and Jeffrey Taylor, President and Chief Operating Officer, are scheduled to present on Monday, February 11, 2008 at the UBS Global Healthcare Services Conference in New York, NY.

Event: 2008 UBS Global Healthcare Services Conference

Date: Monday, February 11, 2008

Time: 9:00 a.m. ET

Place: The Grand Hyatt Hotel, New York, NY

An audio Web cast of the Company's presentations will be available by visiting the investor relations section of IPC's Web site at http://www.hospitalist.com. A replay of the presentation will be available for 15 days.

About IPC The Hospitalist Company

Founded in 1995, IPC The Hospitalist Company, Inc. is a leading provider of hospitalist services in the United States. IPC provides, manages and coordinates the care of hospitalized patients and serves as the inpatient partner of primary care physicians and specialists. IPC delivers physician- driven, hospital-specific solutions to improve the quality of inpatient care. The Company provides its hospitalists with the infrastructure, management systems, information technology, quality insurance programs, training and administrative support necessary to perform these services. IPC employs over 700 medical providers delivering care at over 300 medical facilities and other inpatient facilities in 18 states. For more information, please visit the IPC website at http://www.hospitalist.com.

<
'/>"/>
SOURCE IPC The Hospitalist Company, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. IPC The Hospitalist Company, Inc. Prices Initial Public Offering
2. Hospitalist Physicians Help Shorten Patient Stays
3. Benefits of hospitalist care confirmed in new study
4. ForSight Labs, LLC Announces Formation of Its Third Company, ForSight VISION3, Inc. and Closing of $6 Million in Series A Funding
5. Nevada company, ORNL develop potential lifesaver
6. Tela Sourcing, Inc., an Adaptis Company, Acquires HealthASPex Business
7. Independence Technology, A Johnson & Johnson Company, Renews Its Contract With Creative Technology Services
8. Providence Service Corporation to Present at the 2008 UBS Global Healthcare Services Conference on February 11
9. Triple-S Management Corporation to Present at UBS Global Healthcare Conference
10. Obesity Action Coalition Calls on the State of Mississippi House of Representatives to Withdraw House Bill 282 Discriminating Against Those Affected by Obesity
11. NxStage Medical to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 7, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...Bill Germanakos, the 4th-season winner in the popu...the special guest at two weight management worksho...thodist Mansfield Medical Centers. The workshops, ...re designed to inspire, motivate, and educate peop...ally-managed or and surgical weight loss. , ,...
(Date:1/8/2009)...outh to Become Organ Donors and Provide the Gift o...ire/ -- Jeff Timmons, the founder of the pop band ...lution for all of his fans - sign up today to beco... (Photo: http://www.newscom.com/cgi-bin/prnh/200...person for the newly formed Heather Trew Foundatio...
(Date:1/8/2009)...Compensation Professionals are asked to do more wi...dgets for automation tools are beyond tight. What ...ness case citing real world results which prove th...logy can pay for itself (and then some) in the fir...FL (PRWEB) January 8, 2009 -- HCR Software, a lead...
(Date:1/8/2009)...Praeger to discuss potential Obama healthcare refo... dangers of federal regulation, subsidizing health...re. , Kansas City, Missou...ance Commissioner for the state of Kansas, will ap...ry Hall,s Health Insurance Advocate program hear...
Breaking Medicine News(10 mins):Health News:Methodist Weight Management Institute Brings NBC's 'Biggest Loser' to Dallas and Mansfield 2Health News:Methodist Weight Management Institute Brings NBC's 'Biggest Loser' to Dallas and Mansfield 3Health News:Jeff Timmons and the Heather Trew Foundation Join Forces to Promote Organ Donations 2Health News:Now, More Than Ever, Automating Compensation Planning Is A Good Financial Decision 2Health News:Now, More Than Ever, Automating Compensation Planning Is A Good Financial Decision 3Health News:Kansas Insurance Commissioner, Sandy Praeger, to Appear this Saturday on Cary Hall's Health Insurance Advocate Radio Show 2Health News:Kansas Insurance Commissioner, Sandy Praeger, to Appear this Saturday on Cary Hall's Health Insurance Advocate Radio Show 3
...cancer of the esophagus could be as simple as swal... Thanks to the fervent efforts of Cambridge Univer...0 such cancers that occur in UK every year. It is ...r in the Britain. Once in the windpipe, the pill ...
...d have the maximum number of cardiac patients by 2...style at the earliest. // The above warning has be... Stress, bad eating habits and the growing number...g to the increasing incidence of heart ailments. A...
... monoclonal anti-body (mAb) L2G7 could revolutioni...imary brain tumor. Surgery, chemotherapy and radia...this type of cancer. // However, there is a signi...impairment associated with these treatment forms. ...
...e jailed Indian National in Saudi Arabia, is confi...of this week. The prisoner had been nailed on char...al. // This case has been in the International me...s release was decided after the victim, the Saudi ...
Other Medicine News:Health News:Change In Lifestyle Recommended To Avoid Cardiac Disease 2Health News:Monoclonal Anti-Body To Revolutionize Brain Cancer Treatment 2
(Date:1/7/2009)...REDERICK, Md., Jan. 7 ImQuest Life...n of an IND application to the Food and Drug Admin...eir lead pyrimidinedione HIV inhibitor IQP-0410. I...s in the first quarter of 2009. IQP-0410 is a nove...acts as a nonnucleoside reverse transcriptase inhi...
(Date:1/7/2009)...EIJING, Jan. 7 Tiantan Puhua Hospi...com ), the worldwide leader in using stem cells to...ed today six new globally experienced additions to... expand the hospital,s treatment capabilities for .... The six senior doctors include the distinguished...
(Date:1/6/2009)...rogram Expands on Successful Results from prior U.... Vital Therapies, Inc. (VTI), a de...oday announced patient enrollment has begun for a ...ical trial that will study the Extracorporeal Live... with Acute Liver Failure (ALF) under three protoc...
(Date:1/6/2009)...OMMACK, N.Y., Jan. 6 In recent con... University of Memphis , scientists found that the...), is the first and only proven ingredient to incr...eby increasing blood nitrate/nitrate (NOx) in huma...tor and enables an increase in blood flow to the s...
Breaking Medicine Technology:ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2Nanomedical approach targets multiple cancer genes shrinks tumors more effectively 26443 1Nanomedical approach targets multiple cancer genes shrinks tumors more effectively 26443 2Nanomedical approach targets multiple cancer genes shrinks tumors more effectively 26443 3Study offers new insights into teenagers and anxiety disorders 26439 1Study offers new insights into teenagers and anxiety disorders 26439 2Study offers new insights into teenagers and anxiety disorders 26439 3Study offers new insights into teenagers and anxiety disorders 26439 4Study offers new insights into teenagers and anxiety disorders 26439 5Optical Cable Corporation Schedules Conference Call to Discuss Third Quarter 2008 Results 26435 1Optical Cable Corporation Schedules Conference Call to Discuss Third Quarter 2008 Results 26435 2Optical Cable Corporation Schedules Conference Call to Discuss Third Quarter 2008 Results 26435 3Staten Island University Hospital to Pay the U S 2474 Million to Settle Claims of Defrauding Federal Health Care Programs 26431 1Staten Island University Hospital to Pay the U S 2474 Million to Settle Claims of Defrauding Federal Health Care Programs 26431 2Staten Island University Hospital to Pay the U S 2474 Million to Settle Claims of Defrauding Federal Health Care Programs 26431 3Staten Island University Hospital to Pay the U S 2474 Million to Settle Claims of Defrauding Federal Health Care Programs 26431 4
...a, June 25, 2007 /PRNewswire-FirstCall/ --,Phospha... results,from pre-clinical studies of its TPM-02 d...inoic acid, a leading topical,treatment for severe...cosmetics. , The proof of concept studies showed a...d delivered into the skin when formulated,with TPM...
...gs Reported on Glucose Homeostasis Effects in,Norm...RNewswire-FirstCall/ -- In a 14-day,Phase IIa stu...investigational compound dapagliflozin, a selectiv...GLT2) administered alone or,concomitantly with met...tinuations due to adverse events and no serious ad...
Other Medicine Technology:Phosphagenics Announces Positive Proof of Concept Results from,Studies Utilizing Company's Dermal Drug Delivery Technology 2First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 2First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 3First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 4First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 5First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 6
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
Medicine Products: